Cargando…
Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country
BACKGROUND: Cardiovascular disease (CVD) is a major cause of morbidity and mortality among patients with type 2 diabetes. Statin reduces CVD risk. The ACC/AHA 2018 guideline on dyslipidemia recommends all patients with type 2 diabetes mellitus to be given moderate-intensity statin. We aimed to deter...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263059/ https://www.ncbi.nlm.nih.gov/pubmed/35822081 http://dx.doi.org/10.1007/s13410-022-01107-x |
_version_ | 1784742640861839360 |
---|---|
author | Matthias, Anne Thushara Kaushalya, Jayamini Somathilake, Gayasha Garusinghe, Chaminda |
author_facet | Matthias, Anne Thushara Kaushalya, Jayamini Somathilake, Gayasha Garusinghe, Chaminda |
author_sort | Matthias, Anne Thushara |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease (CVD) is a major cause of morbidity and mortality among patients with type 2 diabetes. Statin reduces CVD risk. The ACC/AHA 2018 guideline on dyslipidemia recommends all patients with type 2 diabetes mellitus to be given moderate-intensity statin. We aimed to determine the prescription practices of statins among patients with type 2 diabetes mellitus. METHODS: A cross-sectional study was conducted from February to April 2021. Patients with type 2 diabetes mellitus between 40 and 75 years were recruited from the University Medical Clinic and Endocrine Clinic at Colombo South Teaching Hospital, Sri Lanka. RESULTS: Four hundred seventy-one patients were enrolled with a mean age of 59.05 (± 9.139) years. The mean duration of diabetes was 10.97 (± 9.57) years. Four hundred forty-one (93.6%) patients were on statin and 30 (6.4%) patients were not on statin therapy. Those not on statins were not prescribed statins. CONCLUSIONS: There were 163 (34.61%) patients who required high intensity. Though only 3 (1.73%) were on high-strength statin, the rest were on moderate (152, 93.25%), low (4, 2.45%), and none (4, 2.45%). Among patients with prior history of atherosclerotic cardiovascular disease (ASCVD) and the high-risk category according to the 10-year ASCVD risk estimation (155, 32.91%), only 17 (10.97%) have achieved optimal LDL therapeutic targets (55mg/dL). A large proportion of the study population received statin therapy for primary and secondary prophylaxis. However, the majority were on suboptimal doses of statin and have not achieved therapeutic targets with regard to LDL-C levels. The findings highlight the importance of improving statin therapy and optimizing lipid management according to evidence-based guideline recommendations. |
format | Online Article Text |
id | pubmed-9263059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-92630592022-07-08 Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country Matthias, Anne Thushara Kaushalya, Jayamini Somathilake, Gayasha Garusinghe, Chaminda Int J Diabetes Dev Ctries Original Article BACKGROUND: Cardiovascular disease (CVD) is a major cause of morbidity and mortality among patients with type 2 diabetes. Statin reduces CVD risk. The ACC/AHA 2018 guideline on dyslipidemia recommends all patients with type 2 diabetes mellitus to be given moderate-intensity statin. We aimed to determine the prescription practices of statins among patients with type 2 diabetes mellitus. METHODS: A cross-sectional study was conducted from February to April 2021. Patients with type 2 diabetes mellitus between 40 and 75 years were recruited from the University Medical Clinic and Endocrine Clinic at Colombo South Teaching Hospital, Sri Lanka. RESULTS: Four hundred seventy-one patients were enrolled with a mean age of 59.05 (± 9.139) years. The mean duration of diabetes was 10.97 (± 9.57) years. Four hundred forty-one (93.6%) patients were on statin and 30 (6.4%) patients were not on statin therapy. Those not on statins were not prescribed statins. CONCLUSIONS: There were 163 (34.61%) patients who required high intensity. Though only 3 (1.73%) were on high-strength statin, the rest were on moderate (152, 93.25%), low (4, 2.45%), and none (4, 2.45%). Among patients with prior history of atherosclerotic cardiovascular disease (ASCVD) and the high-risk category according to the 10-year ASCVD risk estimation (155, 32.91%), only 17 (10.97%) have achieved optimal LDL therapeutic targets (55mg/dL). A large proportion of the study population received statin therapy for primary and secondary prophylaxis. However, the majority were on suboptimal doses of statin and have not achieved therapeutic targets with regard to LDL-C levels. The findings highlight the importance of improving statin therapy and optimizing lipid management according to evidence-based guideline recommendations. Springer India 2022-07-07 2023-06 /pmc/articles/PMC9263059/ /pubmed/35822081 http://dx.doi.org/10.1007/s13410-022-01107-x Text en © The Author(s), under exclusive licence to Research Society for Study of Diabetes in India 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Matthias, Anne Thushara Kaushalya, Jayamini Somathilake, Gayasha Garusinghe, Chaminda Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country |
title | Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country |
title_full | Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country |
title_fullStr | Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country |
title_full_unstemmed | Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country |
title_short | Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country |
title_sort | utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income south asian country |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263059/ https://www.ncbi.nlm.nih.gov/pubmed/35822081 http://dx.doi.org/10.1007/s13410-022-01107-x |
work_keys_str_mv | AT matthiasannethushara utilizationofstatinsinpatientswithtype2diabetesmellitusthepracticeinalowermiddleincomesouthasiancountry AT kaushalyajayamini utilizationofstatinsinpatientswithtype2diabetesmellitusthepracticeinalowermiddleincomesouthasiancountry AT somathilakegayasha utilizationofstatinsinpatientswithtype2diabetesmellitusthepracticeinalowermiddleincomesouthasiancountry AT garusinghechaminda utilizationofstatinsinpatientswithtype2diabetesmellitusthepracticeinalowermiddleincomesouthasiancountry |